Authors
Anna C Need, Joseph P McEvoy, Massimo Gennarelli, Erin L Heinzen, Dongliang Ge, Jessica M Maia, Kevin V Shianna, Min He, Elizabeth T Cirulli, Curtis E Gumbs, Qian Zhao, C Ryan Campbell, Linda Hong, Peter Rosenquist, Anu Putkonen, Tero Hallikainen, Eila Repo-Tiihonen, Jari Tiihonen, Deborah L Levy, Herbert Y Meltzer, David B Goldstein
Publication date
2012/8/10
Journal
The American Journal of Human Genetics
Volume
91
Issue
2
Pages
303-312
Publisher
Elsevier
Description
Schizophrenia is a severe psychiatric disorder with strong heritability and marked heterogeneity in symptoms, course, and treatment response. There is strong interest in identifying genetic risk factors that can help to elucidate the pathophysiology and that might result in the development of improved treatments. Linkage and genome-wide association studies (GWASs) suggest that the genetic basis of schizophrenia is heterogeneous. However, it remains unclear whether the underlying genetic variants are mostly moderately rare and can be identified by the genotyping of variants observed in sequenced cases in large follow-up cohorts or whether they will typically be much rarer and therefore more effectively identified by gene-based methods that seek to combine candidate variants. Here, we consider 166 persons who have schizophrenia or schizoaffective disorder and who have had either their genomes or their …
Total citations
20122013201420152016201720182019202020212022202320245292422711662213